Aker BioMarine has entered into a research collaboration with the Université de Sherbrooke Department of Medicine, to investigate whether LPC-bound EPA/DHA is effective in preventing cognitive decline linked to Alzheimer’s disease. Aker will supply the research team its krill-based LPC EPA/DHA product, Lysoveta.
OSLO, Norway--(BUSINESS WIRE)--With industrial digitalization on the rise, many companies are embracing big data as a solution for improving company processes, and Aker BioMarine is pioneering plant data management like never before. By collaborating with Cognite, a global expert in industrial data, Aker BioMarine is leveraging instant access to data analytics to improve a broad range of processes in its Houston based facility.